Drug intelligence / Profile preview

SPARC001B

Development stage: Unknown
Lead developer: Sun Pharma
Modality: Small Molecules

Overview

SPARC001B is a drug under investigation by Sun Pharma Advanced Research Company Limited. It is currently being evaluated in a bioavailability study, where it is compared against a reference drug, Hydrocodone-acetaminophen. The specific mechanism of action and primary indication for SPARC001B are not detailed in the provided context, but its comparison to Hydrocodone suggests it may be intended for similar therapeutic areas, potentially as an analgesic.

Other names: hydrocodone bitartrate + acetaminophen

Targets

MOR (Mu opioid receptor)COX

Beyond the preview

Go deeper on SPARC001B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPARC001B.

Explore the full profile